Pilo Shlomo - Mar 2, 2025 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Pilo Shlomo
Stock symbol: RAPH
Transactions as of: Mar 2, 2025
Transactions value $: $100,000
Form type: 4
Date filed: 3/11/2025, 04:10 PM
Previous filing: Mar 13, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RAPH	Common Stock	Award	$100K	+200K	+5.29%	$0.50	3.98M	Mar 2, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAPH	Warrant to purchase Common Stock	Award	$0	+100K	+10%	$0.00	1.1M	Mar 2, 2025	Common Stock	100K	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	200,000 shares of Common Stock and 100,000 Warrants to purchase Common Stock of the issuer were acquired by the reporting person for a combined purchase price of $0.50 per share of Common Stock and accompanying Warrant to purchase Common Stock. The Warrants are exercisable immediately and will expire on July 15, 2026.